| Name | Warwick Living Center |
|---|---|
| Location | 842 W Warwick Dr, Alma, Michigan |
| Certified By | Medicare and Medicaid |
| No. of Certified Beds | 45 |
| Occupancy Rate | 67.78% |
| Medicare ID (CCN) | 235607 |
| Legal Business Name | Michigan Masonic Home |
| Ownership Type | Non Profit - Corporation |
| NPI Number | 1144313263 |
| Organization Name | MID-MICHIGAN HEALTH CARE ASSOCIATES,LTD |
| Doing Business As | WARWICK LIVING CENTER |
| Address | 842 W Warwick Drive, Alma, MI 48801 |
| Phone Number | 989-463-2200 |
News Archive
Pharmacists may play an important role in the health care system by filling in health care gaps and advising patients, according to a series of articles in The Los Angeles Times, which reports on one clinical pharmacist Steven Chen and the "Patient Safety and Clinical Pharmacy Services Collaborative, a national project under the Health Resources and Services Administration that is working to integrate clinical pharmacy services into the care of patients with chronic diseases.
CureFAKtor Pharmaceuticals, LLC, a privately-held biopharmaceutical company focused on the research and development of Focal Adhesion Kinase (FAK) inhibitors for cancer, today presented research results at the American Society of Clinical Oncology (ASCO) Gastrointestinal Cancers Symposium in San Francisco demonstrating that novel FAK inhibitors targeting the binding site of vascular endothelial growth factor receptor 3 (VEGFR-3) reduced the growth of pancreatic cancer cells in vitro and in vivo.
OvaGene Oncology Inc., a molecular diagnostics company specializing in the development and commercialization of personalized gene-based diagnostics for gynecologic cancer, announced today that the company has received Clinical Laboratory Improvement Act (CLIA) certification for their newly constructed state-of-the-art molecular diagnostics laboratory.
Final-stage clinical trials of a cervical cancer vaccine developed by University of Queensland (UQ) scientists, have shown the drug to be 100 per cent effective.
Health officials in Britain say they are dealing with the country's first case of a rare strain of tuberculosis (TB) which is almost untreatable.
› Verified 5 days ago
| NPI Number | 1598160137 |
| Organization Name | MICHIGAN MASONIC HOME |
| Doing Business As | WARWICK LIVING CENTER |
| Address | 842 W Warwick Dr, Alma, MI 48801 |
| Phone Number | 989-463-2200 |
News Archive
Pharmacists may play an important role in the health care system by filling in health care gaps and advising patients, according to a series of articles in The Los Angeles Times, which reports on one clinical pharmacist Steven Chen and the "Patient Safety and Clinical Pharmacy Services Collaborative, a national project under the Health Resources and Services Administration that is working to integrate clinical pharmacy services into the care of patients with chronic diseases.
CureFAKtor Pharmaceuticals, LLC, a privately-held biopharmaceutical company focused on the research and development of Focal Adhesion Kinase (FAK) inhibitors for cancer, today presented research results at the American Society of Clinical Oncology (ASCO) Gastrointestinal Cancers Symposium in San Francisco demonstrating that novel FAK inhibitors targeting the binding site of vascular endothelial growth factor receptor 3 (VEGFR-3) reduced the growth of pancreatic cancer cells in vitro and in vivo.
OvaGene Oncology Inc., a molecular diagnostics company specializing in the development and commercialization of personalized gene-based diagnostics for gynecologic cancer, announced today that the company has received Clinical Laboratory Improvement Act (CLIA) certification for their newly constructed state-of-the-art molecular diagnostics laboratory.
Final-stage clinical trials of a cervical cancer vaccine developed by University of Queensland (UQ) scientists, have shown the drug to be 100 per cent effective.
Health officials in Britain say they are dealing with the country's first case of a rare strain of tuberculosis (TB) which is almost untreatable.
› Verified 5 days ago
| Ratings from Surveys (Inspections): | |
| Ratings from Quality Measures: | |
| Ratings from Staffing Data: | |
| Overall Rating: |
|---|
News Archive
Pharmacists may play an important role in the health care system by filling in health care gaps and advising patients, according to a series of articles in The Los Angeles Times, which reports on one clinical pharmacist Steven Chen and the "Patient Safety and Clinical Pharmacy Services Collaborative, a national project under the Health Resources and Services Administration that is working to integrate clinical pharmacy services into the care of patients with chronic diseases.
CureFAKtor Pharmaceuticals, LLC, a privately-held biopharmaceutical company focused on the research and development of Focal Adhesion Kinase (FAK) inhibitors for cancer, today presented research results at the American Society of Clinical Oncology (ASCO) Gastrointestinal Cancers Symposium in San Francisco demonstrating that novel FAK inhibitors targeting the binding site of vascular endothelial growth factor receptor 3 (VEGFR-3) reduced the growth of pancreatic cancer cells in vitro and in vivo.
OvaGene Oncology Inc., a molecular diagnostics company specializing in the development and commercialization of personalized gene-based diagnostics for gynecologic cancer, announced today that the company has received Clinical Laboratory Improvement Act (CLIA) certification for their newly constructed state-of-the-art molecular diagnostics laboratory.
Final-stage clinical trials of a cervical cancer vaccine developed by University of Queensland (UQ) scientists, have shown the drug to be 100 per cent effective.
Health officials in Britain say they are dealing with the country's first case of a rare strain of tuberculosis (TB) which is almost untreatable.
› Verified 5 days ago
| Number of Facility Reported Incidents | 0 |
| Number of Substantiated Complaints | 0 |
| Number of Fines | 0 |
| Total Amount of Fines in Dollars | $0 |
| Number of Payment Denials | 0 |
| Total Number of Penalties | 0 |
| Experience Measure | Provider | National Avg. |
|---|---|---|
| Percentage of long-stay residents whose need for help with daily activities has increased | 11.65 | 14.46 |
| Percentage of long-stay residents who lose too much weight | 3.03 | 5.51 |
| Percentage of low risk long-stay residents who lose control of their bowels or bladder | 23.33 | 48.41 |
| Percentage of long-stay residents with a catheter inserted and left in their bladder | 3.42 | 1.79 |
| Percentage of long-stay residents with a urinary tract infection | 0.88 | 2.65 |
| Percentage of long-stay residents who have depressive symptoms | 0 | 5.05 |
| Percentage of long-stay residents who were physically restrained | 0 | 0.23 |
| Percentage of long-stay residents experiencing one or more falls with major injury | 5.88 | 3.36 |
| Percentage of long-stay residents assessed and appropriately given the pneumococcal vaccine | 100 | 93.87 |
| Percentage of long-stay residents who received an antipsychotic medication | 0 | 14.2 |
| Percentage of short-stay residents assessed and appropriately given the pneumococcal vaccine | 97.97 | 83.88 |
| Percentage of short-stay residents who newly received an antipsychotic medication | 1.46 | 1.79 |
| Percentage of long-stay residents whose ability to move independently worsened | 11.19 | 17.09 |
| Percentage of long-stay residents who received an antianxiety or hypnotic medication | 10.48 | 19.7 |
| Percentage of high risk long-stay residents with pressure ulcers | 7.41 | 7.32 |
| Percentage of long-stay residents assessed and appropriately given the seasonal influenza vaccine | 100 | 95.98 |
| Percentage of short-stay residents who made improvements in function | 84.82 | 67.99 |
| Percentage of short-stay residents who were assessed and appropriately given the seasonal influenza vaccine | 89.47 | 82.93 |
News Archive
Pharmacists may play an important role in the health care system by filling in health care gaps and advising patients, according to a series of articles in The Los Angeles Times, which reports on one clinical pharmacist Steven Chen and the "Patient Safety and Clinical Pharmacy Services Collaborative, a national project under the Health Resources and Services Administration that is working to integrate clinical pharmacy services into the care of patients with chronic diseases.
CureFAKtor Pharmaceuticals, LLC, a privately-held biopharmaceutical company focused on the research and development of Focal Adhesion Kinase (FAK) inhibitors for cancer, today presented research results at the American Society of Clinical Oncology (ASCO) Gastrointestinal Cancers Symposium in San Francisco demonstrating that novel FAK inhibitors targeting the binding site of vascular endothelial growth factor receptor 3 (VEGFR-3) reduced the growth of pancreatic cancer cells in vitro and in vivo.
OvaGene Oncology Inc., a molecular diagnostics company specializing in the development and commercialization of personalized gene-based diagnostics for gynecologic cancer, announced today that the company has received Clinical Laboratory Improvement Act (CLIA) certification for their newly constructed state-of-the-art molecular diagnostics laboratory.
Final-stage clinical trials of a cervical cancer vaccine developed by University of Queensland (UQ) scientists, have shown the drug to be 100 per cent effective.
Health officials in Britain say they are dealing with the country's first case of a rare strain of tuberculosis (TB) which is almost untreatable.
› Verified 5 days ago